Blood Serum in the Treatment of Epitheliopathy of Various Genesis. Clinical Observations
https://doi.org/10.18008/1816-5095-2024-4-769-776
Abstract
The article reviews the results of the use of blood serum in the treatment of epitheliopathy of various genesis. Three clinical cases are presented, each of which was accompanied by epitheliopathy: neurotrophic keratitis (stage I), acanthamoebic keratitis (stage I), and epitheliopathy developed due to toxic-allergic reaction. In epitheliopathy on the background of acanthamoeba keratitis and toxic-allergic reaction, in addition to etiopathogenetic therapy, instillations of autologous serum were used as an adjuvant treatment. In neurotrophic keratopathy autologous serum was used as an independent etiopathogenetic treatment. The serum has neuroprotective, regenerative, anti-infective, anti-inflammatory and tear-replacement properties.
About the Authors
E. A. Kasparova
Krasnov Research Institute of Eye Diseases
Russian Federation
Russian Federation
Kasparova Evgeniya A., PhD, leading research officer of the Optical media of the eye pathology department
Rossolimo str., 11A. B, Moscow, 119021
D. A. Krivolapova
Krasnov Research Institute of Eye Diseases
Russian Federation
Russian Federation
Krivolapova Diana A., postgraduate
Rossolimo str., 11A. B, Moscow, 119021
References
1. Kasparova EA, Marchenko NR. Neurotrophic Keratitis. Etiology, Pathogenesis, Clinical Manifestations. Review. Part 1. Ophthalmology in Russia. 2022;19(1):38– 45. (In Russ.). doi: 10.18008/1816-5095-2022-1-38-45.
2. Pflugfelder SC, Stern ME. The cornea in keratoconjunctivitis sicca. Exp Eye Res. 2020 Dec;201:108295. doi: 10.1016/j.exer.2020.108295. Epub 2020 Oct 7. PMID: 33038387; PMCID: PMC7736263.
3. Safonova TN, Zaitseva GV, Burdennyy AM. Polymorphic markers of certain genes in the development of dry keratoconjunctivitis in patients with rheumatoid arthritis and Sjogren’s syndrome. Russian Annals of Ophthalmology. 2019;135(5):254–259 (In Russ.). doi: 10.17116/oftal-ma2019135052254.
4. Kasparov AA. Ophthalmoherpes. Moscow: Medicine, 1994. 83 p. (In Russ.).
5. Chigbu DI, Labib BA. Pathogenesis and management of adenoviral keratoconjunctivitis. Infect Drug Resist. 2018 Jul 17;11:981–993. doi: 10.2147/IDR.S162669. PMID: 30046247; PMCID: PMC6054290.
6. Marchenko NR, Kasparova EvgA. Diagnosis of Acanthamoeba keratitis. Russian Annals of Ophthalmology. 2016;132(5):103–109 (In Russ.). doi: 10.17116/oftal-ma20161325103-109.
7. Marchenko NR, Kasparova EvgA. Treatment of Acanthamoeba keratitis. Russian Annals of Ophthalmology. 2016;132(5):110–116 (In Russ.). doi: 10.17116/oftalma20161325110-116.
8. Coroi MC, Bungau S, Tit M. PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE. Rom J Ophthalmol. 2015 JanMar;59(1):2–5. PMID: 27373107; PMCID: PMC5729814.
9. Steven DW, Alaghband P, Lim KS. Preservatives in glaucoma medication. Br J Ophthalmol. 2018 Nov;102(11):1497–1503. doi: 10.1136/bjophthalmol2017311544. Epub 2018 Jul 4. PMID: 29973365; PMCID: PMC6241623.
10. Yoon CH, Lee HJ, Park HY, Kim H, Kim MK, Jeoung JW, Oh JY. Effects of topical autologous serum on the ocular surface in patients with toxic corneal epitheliopathy induced by antiglaucoma drugs. Int Ophthalmol. 2020 Mar;40(3):547–552. doi: 10.1007/s10792-019-01211-8. Epub 2019 Nov 8. PMID: 31705358.
11. Trubilin VN, Poluninа EG, Andzhelova DV, Kapkova SG, Kurenkov VV, Chinenova KV. Diseases of the Ocular Surface Associated with Eyelid Makeup and Eyelash Extensions. Clinical Examples. Ophthalmology in Russia. 2019;16(3):386–392 (In Russ.). doi: 10.18008/1816-5095-2019-3-386-392.
12. Kato H, Yokoi N, Watanabe A, Komuro A, Sonomura Y, Sotozono C, Kinoshita S. Clinical Factorsfor Determining the Severity of Lid Wiper Epitheliopathy in Dry Eye. Cornea. 2022 May 1;41(5):545–551. doi: 10.1097/ICO.0000000000002879. PMID: 34690267.
13. Shi WY. Concerns on the diagnosis and treatment of corneal epitheliopathy. Zhonghua Yan Ke Za Zhi. 2017 Mar 11;53(3):161–163. Chinese. doi: 10.3760/cma.j.is-sn.0412-4081.2017.03.001. PMID: 28316188.
14. Dua HS, Said DG, Messmer EM, Rolando M, BenitezDelCastillo JM, Hossain PN, Shortt AJ, Geerling G, Nubile M, Figueiredo FC, Rauz S, Mastropasqua L, Rama P, Baudouin C. Neurotrophic keratopathy. Prog Retin Eye Res. 2018 Sep;66:107–131. doi: 10.1016/j.preteyeres.2018.04.003. Epub 2018 Apr 23. PMID: 29698813.
15. Müller LJ, Marfurt CF, Kruse F, Tervo TM. Corneal nerves: structure, contents and function. Exp Eye Res. 2003 May;76(5):521–542. doi: 10.1016/s0014-4835(03)00050-2. Erratum in: Exp Eye Res. 2003 Aug;77(2):253. PMID: 12697417.
16. Labetoulle M, Baudouin C, Calonge M, MerayoLloves J, Boboridis KG, Akova YA, Aragona P, Geerling G, Messmer EM, BenítezDelCastillo J. Role of corneal nerves in ocular surface homeostasis and disease. Acta Ophthalmol. 2019 Mar;97(2):137– 145. doi: 10.1111/aos.13844. Epub 2018 Sep 17. PMID: 30225941.
17. Posarelli M, Romano D, Tucci D, Giannaccare G, Scorcia V, Taloni A, Pagano L, Borgia A. OcularSurface Regeneration Therapies for Eye Disorders: The State of the Art. BioTech (Basel). 2023 Jun 15;12(2):48. doi: 10.3390/biotech12020048. PMID: 37366796; PMCID: PMC10295950.
18. Vereertbrugghen A, Pizzano M, Sabbione F, Keitelman IA, Shiromizu CM, Aguilar DV, Fuentes F, de Paiva CS, Giordano M, Trevani A, Galletti JG. An ocular Th1 immune response promotes corneal nerve damage independently of the development of corneal epitheliopathy. J Neuroinflammation. 2023 May 22;20(1):120. doi: 10.1186/s12974-023-02800-2. PMID: 37217914; PMCID: PMC10201717.
19. Kasparova EA, Marchenko NR, Surnina ZV, Mitichkina TS. Confocal microscopy in the diagnosis of acanthamoeba keratitis. Russian Annals of Ophthalmology. 2021;137(52):201–208 (In Russ.). doi: 10.17116/oftalma2021137052201.
20. Pozdeyeva NA, Domentyeva LN, Vasilyeva AYu, Ovchinnikova VN. Using the autologous serum in ocular surface diseases. Practical medicine, 2014;1(77):111–115 (In Russ.).
21. Kasparov AA, Kasparova EvgA, Fadeeva LL, Subbot AM, Borodina NV, Kasparova EA, Kobzova MV, Musaeva G, Pavliuk AS. Personalized cell therapy for early postoperative bullous keratopathy (experimental proof and clinical results). Russian Annals of Ophthalmology. 2013;129(5):53–61 (In Russ.).
22. Petrachkov DV, Alkharki L, Matyushchenko AG, Filippov VM, Dudieva FK. Comparison of Early Treatment Outcomes for Large Macular Hole Using Various Surgical Techniques. Ophthalmology in Russia. 2021;18(3S):681–687 (In Russ.).. doi: 10.18008/1816-5095-2021-3S-681-687.
23. Borovkova NV, Filatova IA, Chentsova EV, Fedoseeva EV, Pavlenko YuA, Ponomarev IN, Shemetov SA, Petrova AO. Efficacy of plateletrich plasma lysate in patients with corneal erosion or posttraumatic scarring of the tissues of the eyelids. Russian Ophthalmological Journal. 2020;13(3):8–14 (In Russ.). doi: 10.21516/2072-0076-2020-13-3-8-14.
24. Shtein RM, Shen JF, Kuo AN, Hammersmith KM, Li JY, Weikert MP. Autologous SerumBased Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020 Jan;127(1):128–133. doi: 10.1016/j.ophtha.2019.08.018. Epub 2019 Sep 24. PMID: 31561880.
25. Roumeau S, Dutheil F, Sapin V, Baker JS, Watson SL, Pereira B, Chiambaretta F, Navel V. Efficacy of treatments for neurotrophic keratopathy: a systematic review and metaanalysis. Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2623–2637. doi: 10.1007/s00417-022-05602-z. Epub 2022 Mar 7. PMID: 35254511.
26. Semeraro F, Forbice E, Braga O, Bova A, Di Salvatore A, Azzolini C. Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies. Biomed Res Int. 2014;2014:826970. doi: 10.1155/2014/826970. Epub 2014 Jul 22. PMID: 25136628; PMCID: PMC4130192.
27. Weischnur L, Xanthopoulou K, Munteanu C, Leonhard M, Daas L, Seitz B. Autologe Serumaugentropfen bei therapieresistenten Epitheldefekten der Kornea : Einfluss der Grunderkrankung und einer simultanen Amnionmembrantransplantation bei 990 Anwendungen [Autologous serum eye drops for therapyresistant epithelial defects of the cornea: Impact of underlying disease and simultaneous amniotic transplantation in 990 applications]. Ophthalmologie. 2023 Jan;120(1):43–51. German. doi: 10.1007/s00347-022-01677-5. Epub 2022 Jun 23. PMID: 35925344.
28. Vazirani J, Sridhar U, Gokhale N, Doddigarla VR, Sharma S, Basu S. Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines. Indian J Ophthalmol. 2023 Apr;71(4):1357–1363. doi: 10.4103/IJO.IJO_2756_22. PMID: 37026267; PMCID: PMC10276663.
29. Aggarwal S, Colon C, Kheirkhah A, Hamrah P. Efficacy of autologous serum tears for treatment of neuropathic corneal pain. Ocul Surf. 2019 Jul;17(3):532–539. doi: 10.1016/j.jtos.2019.01.009. Epub 2019 Jan 24. PMID: 30685437; PMCID: PMC6956846.
30. Stenwall PA, Bergström M, Seiron P, Sellberg F, Olsson T, Knutson F, Berglund D. Improving the antiinflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction. Acta Ophthalmol. 2015 Nov;93(7):654– 657. doi: 10.1111/aos.12801. Epub 2015 Jul 14. PMID: 26178796.
31. Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF®Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol. 2012 Aug;37(6):652– 657. doi: 10.1111/j.1365-2230.2011.04303.x. Epub 2012 Feb 14. PMID: 22329713.
32. Wu MF, Stachon T, Seitz B, Langenbucher A, Szentmáry N. Effect of human autologous serum and fetal bovine serum on human corneal epithelial cell viability, migration and proliferation in vitro. Int J Ophthalmol. 2017 Jun 18;10(6):908–913. doi: 10.18240/ijo.2017.06.12. PMID: 28730081; PMCID: PMC5515161.
33. Quinto GG, Campos M, Behrens A. Autologous serum for ocular surface diseases. Arq Bras Oftalmol. 2008 NovDec;71(6 Suppl):47–54. PMID: 19274411.
34. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004 Nov;88(11):1467–474. doi: 10.1136/bjo.2004.044347. PMID: 15489495; PMCID: PMC1772389.
35. CabreraAguas M, Khoo P, Watson SL. Infectious keratitis: A review. Clin Exp Ophthalmol. 2022 Jul;50(5):543–562. doi: 10.1111/ceo.14113. Epub 2022 Jun 3. PMID: 35610943; PMCID: PMC9542356.
36. Amano Y, Sugimoto Y, Sugita M. Ocular disorders due to eyelash extensions. Cornea. 2012 Feb;31(2):121–125. doi: 10.1097/ICO.0b013e31821eea10. PMID: 22134404.
Review
For citations:
Kasparova E.A., Krivolapova D.A. Blood Serum in the Treatment of Epitheliopathy of Various Genesis. Clinical Observations. Ophthalmology in Russia. 2024;21(4):769-776. (In Russ.) https://doi.org/10.18008/1816-5095-2024-4-769-776
Views:
239
Email this article 